Financial health
- Operating income covered interest expense -392.7× in the latest year.
5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $1M | -$12M | 95.7% | -986.6% | — | — | — |
| 2024 | $135000 | -$25M | 100.0% | -13216.3% | — | — | $2M |
| 2023 | $0 | -$26M | — | — | — | $4M | $176000 |
| 2022 | — | -$12M | — | — | — | $8M | $47000 |
| 2021 | — | -$5M | — | — | — | — | $510000 |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $495000 | -$4M | 90.7% | -727.9% | — | — | — |
| Dec '25 | $420000 | -$3M | 97.1% | -718.1% | — | — | — |
| Sep '25 | $183000 | -$3M | 92.3% | -1955.7% | — | — | — |
| Jun '25 | $338000 | -$2M | 92.0% | -519.5% | — | — | $6M |
| Mar '25 | $293000 | -$4M | 100.0% | -1304.4% | — | — | $5M |
| Dec '24 | $67000 | -$4M | 100.0% | -7114.9% | — | — | $2M |
| Sep '24 | $68000 | -$4M | 100.0% | -6552.9% | — | $0 | $2M |
| Jun '24 | $0 | -$3M | — | — | — | $0 | $1M |
| Mar '24 | $0 | -$13M | — | — | — | $1M | $5M |
| Dec '23 | $0 | -$9M | — | — | — | $4M | $176000 |
| Sep '23 | $0 | -$7M | — | — | — | $6M | $73000 |
| Jun '23 | — | -$2M | — | — | — | — | $13000 |
| Mar '23 | — | -$7M | — | — | — | $6M | $725000 |
| Dec '22 | — | -$8M | — | — | — | $8M | $47000 |
| Sep '22 | — | -$2M | — | — | — | — | $49000 |
| Jun '22 | — | -$902000 | — | — | — | — | $613000 |
| Mar '22 | — | -$1M | — | — | — | — | $207000 |
| Sep '21 | — | $235983 | — | — | — | — | $165840 |
| Jun '21 | — | -$2M | — | — | — | — | $339724 |
| Mar '21 | — | $2M | — | — | — | — | $503309 |
How the market has priced ICUCW against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
See the revenue and net-income charts above for SeaStar Medical Holding Corp's multi-year trend.
As of FY2025, SeaStar Medical Holding Corp reported — of total debt against — of cash; operating income covered interest expense -392.7×.
In FY2025, gross margin was 95.7%, operating margin -986.6%, and net margin -984.6%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.